Electronic Portal Imaging Device Dosimetry for IMRT: a Review on Commercially Available Solutions

被引:3
|
作者
Bawazeer, Omemh [1 ,2 ,3 ]
Herath, Sisira [2 ]
Sarasanandarajah, Siva [1 ,2 ]
Deb, Pradip [1 ]
机构
[1] RMIT Univ, Sch Med Sci, Discipline Med Radiat, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Med Phys, Melbourne, Vic, Australia
[3] Umm Al Qura Univ, Sch Med Phys, Discipline Sci, Mecca, Saudi Arabia
关键词
EPID; Dosimetry; IMRT; ALGORITHM; VERIFICATION; IMAGER; GLAAS;
D O I
10.1007/978-3-319-19387-8_135
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Much research has been conducted about the utilization of electronic portal imaging devices (EPID) for dose verification during radiotherapy treatment. Currently a number of commercial solutions are available; Portal Dosimetry, EPIDose, Epiqa, Dosimetry Check, and EPIgray software. Results from separate studies on clinical applications of these solutions are published. The objective of this paper is to review the accuracy of these dosimetry solutions when used for intensity modulated radiotherapy technique (IMRT). Although each solution has a different approach to dose verification, most of the IMRT dosimetry verification results are highly satisfactory. However, performance of one solution is less satisfactory when the patient-couch attenuation occurs. Moreover, none of these solutions correct the backscatter effect resulted from supporting arm. In addition, there are no comparative studies currently available about the accuracy of these solutions except one paper that compared Portal Dosimtery and EPIDose reporting the major differences between these systems. Further studies are needed to compare the accuracy of these commercially available EPID dosimetry solutions.
引用
下载
收藏
页码:553 / 556
页数:4
相关论文
共 50 条
  • [21] An investigation of a new amorphous silicon electronic portal imaging device for transit dosimetry
    Grein, EE
    Lee, R
    Luchka, K
    MEDICAL PHYSICS, 2002, 29 (10) : 2262 - 2268
  • [22] QA for IMRT using electronic portal imaging
    Vieira, SC
    Dirkx, MLP
    de Boer, JC
    Heijmen, B
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S124 - S125
  • [23] A method for in vivo treatment verification of IMRT and VMAT based on electronic portal imaging device
    Jun Zhang
    Xiuqing Li
    Miaomiao Lu
    Qilin Zhang
    Xile Zhang
    Ruijie Yang
    Maria F. Chan
    Junhai Wen
    Radiation Oncology, 16
  • [24] A method for in vivo treatment verification of IMRT and VMAT based on electronic portal imaging device
    Zhang, Jun
    Li, Xiuqing
    Lu, Miaomiao
    Zhang, Qilin
    Zhang, Xile
    Yang, Ruijie
    Chan, Maria F.
    Wen, Junhai
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [25] Transit dosimetry with an electronic portal imaging device (EPID) for 115 prostate cancer patients
    Pasma, KL
    Kroonwijk, M
    Quint, S
    Visser, AG
    Heijmen, BJM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05): : 1297 - 1303
  • [26] Transit Dosimetry for Verification of Dose Delivery Using Electronic Portal Imaging Device (EPID)
    Baek, T.
    Chung, E.
    Lee, S.
    Yoon, M.
    MEDICAL PHYSICS, 2014, 41 (06) : 301 - 301
  • [27] Development and clinical implementation of in-vivo dosimetry using an electronic portal imaging device
    Kroonwijk, M
    Pasma, KL
    Quint, S
    Visser, AG
    Heijmen, BJM
    PROCEEDINGS OF THE XIITH INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY, 1997, : 276 - 278
  • [28] Dosimetry Study On An Amorphous Silicon Electronic Portal Imaging Device(a-Si EPID)
    Wu, Q.
    Hu, Y.
    MEDICAL PHYSICS, 2009, 36 (06) : 2596 - +
  • [29] THE USE OF AN ELECTRONIC PORTAL IMAGING DEVICE FOR EXIT DOSIMETRY AND QUALITY-CONTROL MEASUREMENTS
    KIRBY, MC
    WILLIAMS, PC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (03): : 593 - 603
  • [30] In vivo dosimetry with an electronic portal imaging device for prostate cancer radiotherapy with an endorectal balloon
    Sterckx, Bo
    Steinseifer, Isabell
    Wendling, Markus
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2019, 12 : 7 - 9